Syntec Optics (OPTX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Feb, 2026Executive summary
Achieved net sales of $7.1 million for Q1 2025, a 13% increase year-over-year, driven by growth in medical and defense end markets, partially offset by a decline in communications.
Net income improved to $0.3 million from a loss of $1.2 million in Q1 2024, reflecting higher gross profit and lower general and administrative expenses.
Focus remains on vertically integrated manufacturing for optics and photonics, with continued expansion in defense, medical, consumer, and communications markets.
Financial highlights
Gross profit rose 226% year-over-year to $2.3 million, with gross margin improving to 33% from 11%.
General and administrative expenses decreased 16% to $1.8 million, mainly due to lower advertising and consulting costs.
Adjusted EBITDA was $1.4 million (20% of revenue), up from negative $0.4 million (-6%) in Q1 2024.
Cash at quarter-end was $0.5 million, with $1.7 million available on the line of credit.
Outlook and guidance
Plans to pursue bolt-on acquisitions for inorganic growth in the fragmented photonics industry.
Anticipates further sales growth as product and system offerings expand and customer demand for sophisticated solutions increases.
Latest events from Syntec Optics
- Q2 2026 saw 26% sales growth, record profitability, and improved liquidity via a $21.4M equity raise.OPTX
Q2 2026 - Vertically integrated optics firm with improving margins, strong IP, and enhanced liquidity post-raise.OPTX
Registration filing - Integrated optics and U.S. manufacturing drive growth in space, defense, and AI sectors.OPTX
RedChip Future Tech Investor Conference - Q1 revenue and profit declined on shipment delays, but liquidity improved after a $21.5M offering.OPTX
Q1 2026 - Vertically integrated optics firm seeks $20M IPO to drive acquisitions and growth amid operational risks.OPTX
Registration filing - Q4 2025 marked a profitability inflection, with 2026 growth expected in defense, AI, and optics.OPTX
Q4 2025 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 2025 - Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 2025 - Gross margin rose to 29% in H1 2025 as sales and adjusted EBITDA improved year-over-year.OPTX
Q4 2024